TRISHA PARKER: Open Payments
NPI 1528609187 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,289 in 43 payments from 11 companies in 2025. Trend: 2023 $1,216 · 2024 $1,538 · 2025 $2,289
Food & beverage: $2,289
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $519 |
| ABBVIE INC. | 15 | $473 |
| E.R. Squibb & Sons, L.L.C. | 3 | $272 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $267 |
| Otsuka America Pharmaceutical, Inc. | 4 | $178 |
| Supernus Pharmaceuticals, Inc. | 5 | $145 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Axsome Therapeutics, Inc. | 2 | $46 |
Products named: INVEGA SUSTENNA, VRAYLAR, COBENFY, CAPLYTA, Qelbree, ABILIFY MAINTENA, UZEDY, Auvelity.
Industry payments across VA — which companies pay providers there.
